Philippe Clézardin Selected Research

Philippe Clézardin Research Topics

Disease

57	Neoplasms (Cancer) 01/2021 - 08/2002
54	Neoplasm Metastasis (Metastasis) 11/2021 - 08/2002
42	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2002
21	Bone Resorption 01/2021 - 11/2002
8	Bone Diseases (Bone Disease) 10/2020 - 06/2005
7	Osteolysis 10/2020 - 06/2005
6	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 01/2005
3	Carcinogenesis 01/2021 - 09/2005
3	Multiple Myeloma 01/2015 - 08/2012
2	Disease Progression 09/2011 - 09/2005
2	Melanoma (Melanoma, Malignant) 07/2010 - 11/2008
2	Ovarian Neoplasms (Ovarian Cancer) 06/2006 - 12/2004
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Rheumatoid Arthritis 01/2014
1	Obesity 01/2014
1	Fibrosis (Cirrhosis) 01/2014

Drug/Important Bio-Agent (IBA)

27	Diphosphonates (Bisphosphonates)IBA 12/2018 - 11/2002
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 07/2003
8	Zoledronic Acid (Zometa)FDA Link 12/2018 - 02/2007
7	lysophosphatidic acidIBA 08/2015 - 12/2004
5	MicroRNAs (MicroRNA)IBA 01/2021 - 08/2014
5	Lysophosphatidic Acid ReceptorsIBA 03/2014 - 12/2004
4	Messenger RNA (mRNA)IBA 01/2021 - 09/2011
4	Proteins (Proteins, Gene)FDA Link 12/2018 - 09/2008
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2017 - 06/2007
4	Pharmaceutical PreparationsIBA 01/2016 - 10/2009
4	Risedronic Acid (Actonel)FDA LinkGeneric 11/2012 - 11/2008
4	NitrogenIBA 07/2011 - 09/2008
3	Bone Density Conservation AgentsIBA 11/2021 - 09/2008
3	Cathepsin KIBA 11/2018 - 10/2007
3	PeriostinIBA 11/2018 - 01/2011
3	Conditioned Culture MediaIBA 01/2018 - 12/2006
3	Estrogen ReceptorsIBA 01/2018 - 09/2011
3	OsteoprotegerinIBA 08/2017 - 07/2011
3	Interleukin-6 (Interleukin 6)IBA 01/2017 - 12/2004
2	Monoclonal AntibodiesIBA 01/2021 - 11/2014
2	ERRalpha Estrogen-Related ReceptorIBA 01/2020 - 11/2016
2	Extracellular Matrix ProteinsIBA 11/2018 - 09/2005
2	Interleukin-8 (Interleukin 8)IBA 01/2018 - 12/2004
2	CalciumIBA 12/2017 - 12/2002
2	LigandsIBA 08/2017 - 07/2011
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2017 - 03/2011
2	MineralsIBA 11/2015 - 11/2008
2	LipidsIBA 08/2015 - 01/2009
2	Denosumab FDA Link 06/2015 - 01/2015
2	IntegrinsIBA 11/2014 - 08/2002
2	3- (4- (4- ((1- (2- chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acidIBA 01/2014 - 04/2012
2	Clodronic Acid (Clodronate)IBA 02/2013 - 02/2007
2	AndrogensIBA 01/2013 - 01/2005
2	Biological ProductsIBA 12/2012 - 01/2009
2	indolepropanol phosphate (IPP)IBA 11/2012 - 07/2011
2	LuciferasesIBA 01/2008 - 02/2007
2	Green Fluorescent ProteinsIBA 06/2007 - 02/2007
2	adhesion receptorIBA 06/2007 - 08/2002
2	CytokinesIBA 06/2006 - 12/2004
1	Long Noncoding RNAIBA 01/2021
1	Circular RNAIBA 01/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	Integrin alpha5IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	volociximabIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2020
1	NexusIBA 01/2020
1	ChemokinesIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 12/2018
1	Interleukin-11 (Interleukin 11)IBA 01/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	EpiregulinIBA 08/2017
1	Epidermal Growth Factor (EGF)IBA 08/2017
1	Calcium-Sensing ReceptorsIBA 08/2017
1	A-Form DNA (A-DNA)IBA 08/2017
1	Drug CarriersIBA 10/2015
1	ClathrinIBA 10/2015
1	Zinc Finger E-box-Binding Homeobox 1IBA 08/2015
1	Calcium Channels (Calcium Channel)IBA 09/2014
1	Tyrosine Kinase InhibitorsIBA 09/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2014
1	Neutralizing AntibodiesIBA 09/2014
1	vatalanib (PTK787)IBA 09/2014
1	Bevacizumab (Avastin)FDA Link 09/2014
1	Doxycycline (Periostat)FDA LinkGeneric 08/2014
1	Transcription Factors (Transcription Factor)IBA 08/2014
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2014
1	Estrogens (Estrogen)FDA Link 02/2013
1	Mevalonic Acid (Mevalonate)IBA 11/2012
1	Cell Surface ReceptorsIBA 11/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2012
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2012
1	farnesyl pyrophosphate (farnesyl diphosphate)IBA 11/2012
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2012

Therapy/Procedure

24	Therapeutics 01/2021 - 11/2002
3	Drug Therapy (Chemotherapy) 02/2013 - 12/2010
2	Radiotherapy 11/2021 - 10/2020
2	Palliative Care (Palliative Therapy) 10/2020 - 01/2003
2	Castration 11/2016 - 01/2013
2	Intravenous Injections 03/2010 - 02/2007
1	Neoadjuvant Therapy 12/2018